 INmune Bio, Inc. INMB, a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, announced today that RJ Tesi, MD, CEO and CMO of INmune Bio will participate on a COVID-19 therapeutics panel discussion, at Maxim Groups Infectious Disease Virtual Conference at 3:45pm ET, on Tuesday, May 5, 2020. Dr. Tesi will discuss treating COVID-19 as an inflammatory disease. 